Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression

Abstract Background Streptomyces roseochromogenes NRRL 3504 produces clorobiocin, an aminocoumarin antibiotic that inhibits DNA replication. No other natural products have been isolated from this bacterium so far, despite the presence of a rich repertoire of specialized metabolite biosynthesis gene...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofiia Melnyk, Marc Stierhof, Dmytro Bratiichuk, Franziska Fries, Rolf Müller, Yuriy Rebets, Andriy Luzhetskyy, Bohdan Ostash
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Microbial Cell Factories
Subjects:
Online Access:https://doi.org/10.1186/s12934-024-02621-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594372005199872
author Sofiia Melnyk
Marc Stierhof
Dmytro Bratiichuk
Franziska Fries
Rolf Müller
Yuriy Rebets
Andriy Luzhetskyy
Bohdan Ostash
author_facet Sofiia Melnyk
Marc Stierhof
Dmytro Bratiichuk
Franziska Fries
Rolf Müller
Yuriy Rebets
Andriy Luzhetskyy
Bohdan Ostash
author_sort Sofiia Melnyk
collection DOAJ
description Abstract Background Streptomyces roseochromogenes NRRL 3504 produces clorobiocin, an aminocoumarin antibiotic that inhibits DNA replication. No other natural products have been isolated from this bacterium so far, despite the presence of a rich repertoire of specialized metabolite biosynthesis gene clusters (smBGCs) within its genome. Heterologous expression of smBGCs in suitable chassis speeds up the discovery of the natural products hidden behind these sets of genes. Results In this work we focus on one intriguing smBGC of NRRL 3504 bearing some similarity to gene clusters involved in production of manumycin family polyketides. Through heterologous expression in Streptomyces chassis strains S. albus Del14 and S. lividans ΔYA9, this smBGC (hereafter referred to as lim BGC) was shown to direct the production of unusual polyketide limocrocin (LIM) known for its ability to interfere with viral reverse transcriptases. The organization of lim BGC, data on the structures of revealed metabolites as well as manipulations of lim genes allowed us to put forward an initial hypothesis about a biosynthetic pathway leading to LIM. We provide initial data on two LIM derivatives as well as updated NMR spectra for the main product. Conclusion This study reveals the genetic control of biosynthesis of LIM that remained hidden for the last 70 years. This, in turn, opens the door to biological routes towards overproduction of LIM as well as generation of its derivatives.
format Article
id doaj-art-d312f632f66d454f86887ed648df0ac4
institution Kabale University
issn 1475-2859
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Microbial Cell Factories
spelling doaj-art-d312f632f66d454f86887ed648df0ac42025-01-19T12:44:17ZengBMCMicrobial Cell Factories1475-28592025-01-0124111410.1186/s12934-024-02621-9Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expressionSofiia Melnyk0Marc Stierhof1Dmytro Bratiichuk2Franziska Fries3Rolf Müller4Yuriy Rebets5Andriy Luzhetskyy6Bohdan Ostash7Department of Genetics and Biotechnology, Ivan Franko National University of LvivHelmholtz Institute for Pharmaceutical Research Saarland (HIPS)Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland UniversityHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland UniversityExplogen LLCHelmholtz Institute for Pharmaceutical Research Saarland (HIPS)Department of Genetics and Biotechnology, Ivan Franko National University of LvivAbstract Background Streptomyces roseochromogenes NRRL 3504 produces clorobiocin, an aminocoumarin antibiotic that inhibits DNA replication. No other natural products have been isolated from this bacterium so far, despite the presence of a rich repertoire of specialized metabolite biosynthesis gene clusters (smBGCs) within its genome. Heterologous expression of smBGCs in suitable chassis speeds up the discovery of the natural products hidden behind these sets of genes. Results In this work we focus on one intriguing smBGC of NRRL 3504 bearing some similarity to gene clusters involved in production of manumycin family polyketides. Through heterologous expression in Streptomyces chassis strains S. albus Del14 and S. lividans ΔYA9, this smBGC (hereafter referred to as lim BGC) was shown to direct the production of unusual polyketide limocrocin (LIM) known for its ability to interfere with viral reverse transcriptases. The organization of lim BGC, data on the structures of revealed metabolites as well as manipulations of lim genes allowed us to put forward an initial hypothesis about a biosynthetic pathway leading to LIM. We provide initial data on two LIM derivatives as well as updated NMR spectra for the main product. Conclusion This study reveals the genetic control of biosynthesis of LIM that remained hidden for the last 70 years. This, in turn, opens the door to biological routes towards overproduction of LIM as well as generation of its derivatives.https://doi.org/10.1186/s12934-024-02621-9LimocrocinGenesHeterologous expressionBiosynthetic gene clusterReverse transcriptase inhibitor
spellingShingle Sofiia Melnyk
Marc Stierhof
Dmytro Bratiichuk
Franziska Fries
Rolf Müller
Yuriy Rebets
Andriy Luzhetskyy
Bohdan Ostash
Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
Microbial Cell Factories
Limocrocin
Genes
Heterologous expression
Biosynthetic gene cluster
Reverse transcriptase inhibitor
title Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
title_full Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
title_fullStr Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
title_full_unstemmed Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
title_short Uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
title_sort uncovering the genetic basis of antiviral polyketide limocrocin biosynthesis through heterologous expression
topic Limocrocin
Genes
Heterologous expression
Biosynthetic gene cluster
Reverse transcriptase inhibitor
url https://doi.org/10.1186/s12934-024-02621-9
work_keys_str_mv AT sofiiamelnyk uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT marcstierhof uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT dmytrobratiichuk uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT franziskafries uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT rolfmuller uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT yuriyrebets uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT andriyluzhetskyy uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression
AT bohdanostash uncoveringthegeneticbasisofantiviralpolyketidelimocrocinbiosynthesisthroughheterologousexpression